MIR002
MIR002 is a potent and orally active DNA polymerase α (POLA1) and HDAC 11 dual inhibitor. MIR002 induces acetylation of p53, activation of p21, G1/S cell cycle arrest, and apoptosis. MIR002 shows significant antitumor activity in vivo[1].
Product Specifications
CAS Number
2217671-64-0
UNSPSC
12352005
Target
Apoptosis; DNA/RNA Synthesis; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mir002.html
Purity
99.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ONC(COC1=C(C=C(C2=CC=C(C=C2)/C=C/C(O)=O)C=C1)C34CC5CC(CC(C5)C4)C3)=O
Molecular Formula
C27H29NO5
Molecular Weight
447.52
References & Citations
[1]Dallavalle S, et al. Antitumor activity of novel POLA1-HDAC11 dual inhibitors. Eur J Med Chem. 2022, 228:113971.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC11
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Ethyl 3-cyanopyrazolo[1,5-a]pyrimidine-7-carboxylate](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
Ethyl 3-cyanopyrazolo[1,5-a]pyrimidine-7-carboxylate
Ethyl 3-cyanopyrazolo[1,5-a]pyrimidine-7-carboxylate
Protein Phosphatase 1 beta (PPP1CB) (NM_002709) Human Over-expression Lysate
